During the past decade, Botucatu Medical School São Paulo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Botucatu Medical School São Paulo" are "Respiratory Syncytial Virus Infections" (1 trials) and "Respiratory Tract Infections" (1 trials). Many other conditions were trialed in "Botucatu Medical School São Paulo" in a lesser frequency.

Most popular intervention types in "Botucatu Medical School São Paulo" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "JNJ-53718678" (1 trials), "Rilematovir" (1 trials) and "Rilematovir X mg/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Botucatu Medical School São Paulo" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Botucatu Medical School São Paulo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Botucatu Medical School São Paulo, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Botucatu Medical School São Paulo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".